Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.Richard W. Joseph, Richard Kefford, David C. Turner et al.|Journal of Clinical Oncology|2015Cited by 6